Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid - PubMed (original) (raw)

Multicenter Study

. 2021 Feb 18;59(3):e02497-20.

doi: 10.1128/JCM.02497-20. Print 2021 Feb 18.

Johannes Bacher 1, Sandra Barth 1, Faranak Atrzadeh 2, Katja Siebenhaller 1, Inês Ferreira 3, Stephan Beisken 3, Andreas E Posch 3, Karen C Carroll 4, Richard G Wunderink 5, Chao Qi 6, Fann Wu 7, Dwight J Hardy 8, Robin Patel 9 10, Matthew D Sims 11 12 13

Affiliations

Multicenter Study

Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid

Matthias Klein et al. J Clin Microbiol. 2021.

Abstract

Bronchoalveolar lavage (BAL) culture is a standard, though time-consuming, approach for identifying microorganisms in patients with severe lower respiratory tract (LRT) infections. The sensitivity of BAL culture is relatively low, and prior antimicrobial therapy decreases the sensitivity further, leading to overuse of empirical antibiotics. The Unyvero LRT BAL Application (Curetis GmbH, Germany) is a multiplex molecular panel that detects 19 bacteria, 10 antibiotic resistance markers, and a fungus, Pneumocystis jirovecii, in BAL fluid in ∼4.5 h. Its performance was evaluated using 1,016 prospectively collected and 392 archived specimens from 11 clinical trial sites in the United States. Overall positive and negative percent agreements with culture results for identification of bacteria that grow in routine cultures were 93.4% and 98.3%, respectively, with additional potential pathogens identified by Unyvero in 21.7% of prospectively collected specimens. For detection of P. jirovecii, the positive percent agreement with standard testing was 87.5%. Antibiotic resistance marker results were compared to standard antibiotic susceptibility test results to determine positive predictive values (PPVs). PPVs ranged from 80 to 100%, based on the microorganism and specific resistance marker(s). The Unyvero LRT BAL Application provides accurate detection of common agents of bacterial pneumonia and of P. jirovecii The sensitivity and rapidity of this panel suggest significant clinical value for choosing appropriate antibiotics and for antibiotic stewardship.

Keywords: BAL; molecular diagnostics; multiplex PCR; pneumonia.

Copyright © 2021 American Society for Microbiology.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Del Rio-Pertuz G, Gutiérrez JF, Triana AJ, Molinares JL, Robledo-Solano AB, Meza JL, Ariza-Bolívar OM, Acosta-Reyes J, Garavito A, Viasus D, Carratalà J. 2019. Usefulness of sputum gram stain for etiologic diagnosis in community-acquired pneumonia: a systematic review and meta-analysis. BMC Infect Dis 19:403. doi:10.1186/s12879-019-4048-6. - DOI - PMC - PubMed
    1. O'Horo JC, Thompson D, Safdar N. 2012. Is the Gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. Clin Infect Dis 55:551–561. doi:10.1093/cid/cis512. - DOI - PubMed
    1. Kim ES, Kim E-C, Lee S-M, Yang S-C, Yoo C-G, Kim YW, Han SK, Yim J-J. 2012. Bacterial yield from quantitative cultures of bronchoalveolar lavage fluid in patients with pneumonia on antimicrobial therapy. Korean J Intern Med 27:156–162. doi:10.3904/kjim.2012.27.2.156. - DOI - PMC - PubMed
    1. Fernando SM, Tran A, Cheng W, Klompas M, Kyeremanteng K, Mehta S, English SW, Muscedere J, Cook DJ, Torres A, Ranzani OT, Fox-Robichaud AE, Alhazzani W, Munshi L, Guyatt GH, Rochwerg B. 2020. Diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis. Intensive Care Med 46:1170–1179. doi:10.1007/s00134-020-06036-z. - DOI - PMC - PubMed
    1. Torres A, Lee N, Cilloniz C, Vila J, Van der Eerden M. 2016. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J 48:1764–1778. doi:10.1183/13993003.01144-2016. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources